Long-term estrogen therapy improves vascular function in male to female transsexuals

Journal of the American College of Cardiology

Volumn 29, Issue 7, 1997, Pages 1437-1444

  New, Gishel ^a   Timmins, Katrina L ^a   Duffy, Stephen J ^a   Tran, Binh T ^a   O'Brien, Richard C ^a   Harper, Richard W ^a   Meredith, Ian T ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; ESTROGEN; GLYCERYL TRINITRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TESTOSTERONE;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; ESTROGEN THERAPY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIVARIATE ANALYSIS; PARTICLE SIZE; PREMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; TRANSSEXUALISM; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

ADULT; BLOOD VESSELS; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; ESTRADIOL CONGENERS; FEMALE; HUMANS; MALE; MIDDLE AGED; TESTOSTERONE; TRANSSEXUALISM; TRIGLYCERIDES; VASODILATION;

EID: 0030941248     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00080-6     Document Type: Article

References (39)

1. Castelli WP. Epidemiology of coronary heart disease the Framingham Study . Am J Med. 76:1984;4-12.
2. Sullivan JM, Vander Zwaag R, Hughes JP, et al. Estrogen replacement and coronary artery disease effect on survival in postmenopausal women . Arch Intern Med. 150:1996;2557-2562.
3. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 265:1991;1861-1867.
4. Reis SE, Gloth ST, Blumenthal RS, et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
5. Lieberman EH, Gerhard MD, Uehata A, et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in post-menopausal women. Ann Intern Med. 121:1994;936-941.
6. Van Buren GA, Yang D, Clark KE. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 167:1992;828-833.
7. The Coronary Drug Project. JAMA. 226:1973;652-657.
8. Robinson RW, Higano N, Cohen WD. Long-term effects of high dosage estrogen therapy in men with coronary heart disease. J Chronic Dis. 16:1963;155-161.
9. Stamler J, Katz LN, Pick R, et al. Effects of long-term estrogen therapy on serum cholesterol-lipid-lipoprotein levels and on mortality in middle-aged men with previous myocardial infarction. Circulation. 22:1960;658.
10. Marmorston J, Moore FJ, Kuzma OT, et al. Effects of Premarin on survival in men with myocardial infarction. Proc Soc Exp Biol. 105:1960;618.
11. Pyndath TI, Chanapai S. Elevation of serum HDL and HDL cholesterol in cholesterol-fed male rabbits treated with estrogen. Atherosclerosis. 38:1981;255-265.
12. Damewood MD, Bellantoni JJ, Bachorik PS, et al. Exogenous estrogen effect on lipid/lipoprotein cholesterol in transsexual males. J Endocrinol Invest. 12:1989;449-454.
13. Hashimoto M, Akishita M, Eto M, et al. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation. 92:1995;3431-3435.
14. Risk Factor Prevalence Study Management Committee. Risk Factor Prevalence Study: Survey No. 3 1989. Canberra: National Heart Foundation of Australia and Australian Institute of Health, 1990.
15. Celemajer DS, Sorenson KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
16. Celermajer DS, Sorenson KE, Georgakopoulos D, et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88(Pt 1):1993;2149-2155.
17. Tagawa H, Tagawa T, Shimokawa H. Estrogen acutely improves nitric-oxide mediated and non-nitric oxide mediated endothelium-dependent vasodilation in postmenopausal women [abstract]. Circulation. 92:(Suppl I):1995;I-68.
18. Gilligan DM, Badar DM, Panza JA, et al. Acute vascular effects of estrogen in postmenopausal women. Circulation. 90:1994;786-791.
19. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 91:1995;1314-1319.
20. Chester AH, Jiang C, Borland JA, et al. Estrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coronary Art Dis. 6:1995;417-422.
21. Sudhir K, Chou TM, Mullen WL, et al. Mechanism of estrogen-induced vasodilation in vivo studies in canine coronary conductance and resistance arteries . J Am Coll Cardiol. 26:1995;807-814.
22. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol. 106:1992;739-745.
23. Weiner CP, Lizasoain I, Baylis SA, et al. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
24. Keaney JF, Shwaery GT, Xu A, et al. 17β-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 89:1994;2251-2259.
25. Jiang C, Sarrel PM, Poole-Wilson PA, et al. Acute effect of 17β-estradiol on rabbit coronary artery responses to endothelin-1. Am J Physiol. 263:1992;H271-H275.
26. Polderman KH, Stehouwer CDA, Van Kamp GJ, et al. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 118:1993;429-432.
27. Harder DR, Coulson PB. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J Cell Physiol. 100:1979;375-382.
28. White MM, Zamudio S, Stevens T, et al. Estrogen, progesterone, and vascular reactivity potential cellular mechanisms . Endocrinol Rev. 16:1995;739-751.
29. Blumenthal RS, Gloth ST, Reis SE, et al. Acute administration of estrogen improves coronary vasomotor response to acetylcholine in men [abstract]. J Am Coll Cardiol. 27:(Suppl A):1996;287A.
30. Collins P, Rosano MC, Sarrel PM, et al. 17b-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:1995;24-30.
31. Moorjani S, Dupont A, Labrie F, et al. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma effects of orchidectomy, estrogen, and combination treatment with lutenizing hormone-releasing hormone agonist and flutamide . J Clin Endocrinol Metab. 66:1988;314-322.
32. Kuhn FE, Mohler ER, Satler LF, et al. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am J Cardiol. 68:1991;1425-1430.
33. Anderson TJ, Meredith IT, Yeung AC, et al. The effects of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
34. Crouse JR, Parks JS, Schey HM, et al. Studies of low-density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res. 26:1985;566-574.
35. Blackard CE, Doe RP, Mellinger GT, et al. Incidence of cardiovascular disease and death in patients receiving diethylstillboestrol for carcinoma of the prostate. Cancer. 26:1970;249-256.
36. Herman M, Adams MR, Mc Credie RJ, et al. Androgen deprivation is associated with improved endothelial function in adult men [abstract]. Circulation. 94:(Suppl I):1996;I-278.
37. Chou TM, Sudhir K, Hutchison SJ, et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 94:1996;2614-2619.
38. Yue P, Chatterjee K, Beale C, et al. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 91:1995;1154-1160.
39. Costarella CE, Stallone JN, Rutecki GW, et al. Testosterone causes direct relaxation of rat thoracic aorta. J Pharmacol Exp Ther. 277:1996;34-39.